Back to Search
Start Over
Reply to: "Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?"
- Source :
-
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2021 Mar; Vol. 53 (3), pp. 385-386. Date of Electronic Publication: 2021 Jan 25. - Publication Year :
- 2021
-
Abstract
- Competing Interests: Conflict of Interest None declared.
Details
- Language :
- English
- ISSN :
- 1878-3562
- Volume :
- 53
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
- Publication Type :
- Editorial & Opinion
- Accession number :
- 33509738
- Full Text :
- https://doi.org/10.1016/j.dld.2021.01.014